CVS' Caremark leans on biosimilars and AI to combat rising drug costs

By Allison Bell

News October 30, 2025 at 04:32 PM

Share & Print

What You Need To Know

During the CVS Health earnings call, employers came up only during talk about the Caremark pharmacy benefit manager unit..
One executive said Caremark had trouble increasing charges quickly enough in the third quarter.
Another executive cited biosimilars and AI as tools that Caremark can use to improve its performance.could help Caremark improve its

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.